219 related articles for article (PubMed ID: 31576457)
1. Asymmetric dimethylarginine aggravates blood-retinal barrier breakdown of diabetic retinopathy via inhibition of intercellular communication in retinal pericytes.
Huang CY; Zhou T; Li G; Li MY; Xiong XM; Wu MT; Jiang JL
Amino Acids; 2019 Nov; 51(10-12):1515-1526. PubMed ID: 31576457
[TBL] [Abstract][Full Text] [Related]
2. High glucose alters Cx43 expression and gap junction intercellular communication in retinal Müller cells: promotes Müller cell and pericyte apoptosis.
Muto T; Tien T; Kim D; Sarthy VP; Roy S
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4327-37. PubMed ID: 24938518
[TBL] [Abstract][Full Text] [Related]
3. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
[TBL] [Abstract][Full Text] [Related]
4. Asymmetric dimethylarginine contributes to retinal neovascularization of diabetic retinopathy through EphrinB2 pathway.
Du MR; Yan L; Li NS; Wang YJ; Zhou T; Jiang JL
Vascul Pharmacol; 2018 Sep; 108():46-56. PubMed ID: 29777874
[TBL] [Abstract][Full Text] [Related]
5. PRMT-1 and DDAHs-induced ADMA upregulation is involved in ROS- and RAS-mediated diabetic retinopathy.
Chen Y; Xu X; Sheng M; Zhang X; Gu Q; Zheng Z
Exp Eye Res; 2009 Dec; 89(6):1028-34. PubMed ID: 19748504
[TBL] [Abstract][Full Text] [Related]
6. Asymmetric dimethylarginine damages connexin43-mediated endothelial gap junction intercellular communication.
Jia SJ; Zhou Z; Zhang BK; Hu ZW; Deng HW; Li YJ
Biochem Cell Biol; 2009 Dec; 87(6):867-74. PubMed ID: 19935872
[TBL] [Abstract][Full Text] [Related]
7. High glucose alters connexin 43 expression and gap junction intercellular communication activity in retinal pericytes.
Li AF; Sato T; Haimovici R; Okamoto T; Roy S
Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5376-82. PubMed ID: 14638741
[TBL] [Abstract][Full Text] [Related]
8. The effect of total lignans from Fructus Arctii on Streptozotocin-induced diabetic retinopathy in Wistar rats.
Zhang H; Gao Y; Zhang J; Wang K; Jin T; Wang H; Ruan K; Wu F; Xu Z
J Ethnopharmacol; 2020 Jun; 255():112773. PubMed ID: 32199990
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomics analysis of pericytes from retinas of diabetic animals reveals novel genes and molecular pathways relevant to blood-retinal barrier alterations in diabetic retinopathy.
Rangasamy S; Monickaraj F; Legendre C; Cabrera AP; Llaci L; Bilagody C; McGuire P; Das A
Exp Eye Res; 2020 Jun; 195():108043. PubMed ID: 32376470
[TBL] [Abstract][Full Text] [Related]
10. Effects of high glucose-induced Cx43 downregulation on occludin and ZO-1 expression and tight junction barrier function in retinal endothelial cells.
Tien T; Barrette KF; Chronopoulos A; Roy S
Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6518-25. PubMed ID: 24008412
[TBL] [Abstract][Full Text] [Related]
11. Cell-cell communication in diabetic retinopathy.
Roy S; Kim D; Lim R
Vision Res; 2017 Oct; 139():115-122. PubMed ID: 28583293
[TBL] [Abstract][Full Text] [Related]
12. Reduced connexin 43 expression and its effect on the development of vascular lesions in retinas of diabetic mice.
Bobbie MW; Roy S; Trudeau K; Munger SJ; Simon AM; Roy S
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3758-63. PubMed ID: 20130277
[TBL] [Abstract][Full Text] [Related]
13. TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis.
Huang H; Gandhi JK; Zhong X; Wei Y; Gong J; Duh EJ; Vinores SA
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1336-44. PubMed ID: 21212173
[TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic Acid Attenuates Endoplasmic Reticulum Stress-Related Retinal Pericyte Loss in Streptozotocin-Induced Diabetic Mice.
Chung YR; Choi JA; Koh JY; Yoon YH
J Diabetes Res; 2017; 2017():1763292. PubMed ID: 28127564
[TBL] [Abstract][Full Text] [Related]
15. Role of phospholipases A2 in diabetic retinopathy: in vitro and in vivo studies.
Lupo G; Motta C; Giurdanella G; Anfuso CD; Alberghina M; Drago F; Salomone S; Bucolo C
Biochem Pharmacol; 2013 Dec; 86(11):1603-13. PubMed ID: 24076420
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
[TBL] [Abstract][Full Text] [Related]
17. Increased Ephrin-B2 expression in pericytes contributes to retinal vascular death in rodents.
Coucha M; Barrett AC; Bailey J; Abdelghani M; Abdelsaid M
Vascul Pharmacol; 2020 Aug; 131():106761. PubMed ID: 32585189
[TBL] [Abstract][Full Text] [Related]
18. Vascular Pericyte Impairment and Connexin43 Gap Junction Deficit Contribute to Vasomotor Decline in Diabetic Retinopathy.
Ivanova E; Kovacs-Oller T; Sagdullaev BT
J Neurosci; 2017 Aug; 37(32):7580-7594. PubMed ID: 28674171
[TBL] [Abstract][Full Text] [Related]
19. The emerging roles of clusterin on reduction of both blood retina barrier breakdown and neural retina damage in diabetic retinopathy.
Zhang C; Nie J; Feng L; Luo W; Yao J; Wang F; Wang H
Discov Med; 2016 Apr; 21(116):227-37. PubMed ID: 27232509
[TBL] [Abstract][Full Text] [Related]
20. Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats.
Gonçalves A; Marques C; Leal E; Ribeiro CF; Reis F; Ambrósio AF; Fernandes R
Biochim Biophys Acta; 2014 Sep; 1842(9):1454-63. PubMed ID: 24769045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
